Cardio Diagnostics Holdings, Inc.

Healthcare · Biotechnology · United States

Last price 1.67 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.94M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic...